Radiation Free Study
A legfontosabb adatok
- Hol
- Birmingham, Boston, Dallas, Philadelphia és Worcester (Egyesült Államok)Mind a 5 helyszín megnézése
Helyszínek itt: Egyesült Államok
- University of AlabamaBirmingham, Egyesült ÁllamokContact: Adam Beck (principal investigator)Résztvevőt keres
- Beth Israel Deaconess Medical CenterBoston, Egyesült ÁllamokContact: Marc Schermerhorn (principal investigator)Toborzás még nem indult
- University of Texas Southwestern Medical CenterDallas, Egyesült ÁllamokContact: Mirza Baig (principal investigator)Résztvevőt keres
- University of PennsylvaniaPhiladelphia, Egyesült ÁllamokContact: Darren Schneider (principal investigator)Résztvevőt keres
- University of MassachusettsWorcester, Egyesült ÁllamokContact: Andres Schanzer (principal investigator)Résztvevőt keres
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- Philips Clinical & Medical Affairs Global
- Azonosító
- NCT06549348
- A regiszteradat frissítve
- 2026. június 15.
- Eredeti leírás
This is a prospective, randomized, unblinded, multi-center study. Sites were selected from different geographies (EU and US) with different clinical practice to ensure the results are more generalizable.A teljes eredeti leírásKevesebb
This is a prospective, randomized, unblinded, multi-center study. Sites were selected from different geographies (EU and US) with different clinical practice to ensure the results are more generalizable.
Primary objective is to demonstrate that the average procedure fluoroscopy time using LumiGuide is lower compared to conventional fluoroscopy guidance in Fenestrated Endovascular Aortic Repair (FEVAR)
Bevonási feltételek: Subject will be undergoing a primary Fenestrated Endovascular Aortic Repair (FEVAR) procedure (including subjects with prior infrarenal EVAR or open repair) that includes the incorporation of visceral arteries into the repair; Subject is able to give informed consent and is 18 years of age or older, or of legal age to give informed consent per state or national law; Subject has a life expectancy of at least 2 years; Target vessels to be included are the Celiac Trunk, Superior Mesenteric Artery and Renal Arteries.
Kizáró feltételek: Subject participates in a potentially confounding drug or device trial during the course of the study. Co-enrollment in concurrent trials may be allowed provided that pre-approval is obtained from Philips; Subject with connective tissue disorder eg, Marfan's or Ehlers Danlos Syndrome; Subject with contrast allergies; Subjects undergoing an endovascular procedure that include branches or iliac branched devices (IBD) in the repair; Subject treated for re-intervention / staged procedure post-primary FEVAR procedure; Subjects intended to be treated for more than 4 target vessels (not counting the contralateral gate); Subject treated for an emergent (<24hrs after emergence) procedure; All vulnerable subjects such as immuno-compromised subjects, subjects lacking the capacity to provide consent, patients in emergency situations, pregnant or breast-feeding women, or any other subject who meets an exclusion criteria, according to applicable national laws, if any; Subject unwilling or unable to comply with the protocol unable to understand verbal and/or written informed consent.